These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10326547)

  • 1. Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer.
    Maraj BH; Aldersley MA; Markham AF
    Lancet; 1998 May; 351(9115):1559-60. PubMed ID: 10326547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of PSA mRNA and PSMA mRNA by means of RT-PCR].
    Deguchi T; Yamamoto N; Ehara H; Takahashi Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():150-3. PubMed ID: 11022704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current value of prostate specific membrane antigen].
    Ito T; Yamamoto S
    Nihon Rinsho; 2000 Jul; 58 Suppl():154-6. PubMed ID: 11022705
    [No Abstract]   [Full Text] [Related]  

  • 4. A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?
    Tasch J; Gong M; Sadelain M; Heston WD
    Crit Rev Immunol; 2001; 21(1-3):249-61. PubMed ID: 11642607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
    Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report on Prostate Cancer Tumor Marker Workshop 1999.
    Partin AW; Murphy GP; Brawer MK
    Cancer; 2000 Feb; 88(4):955-63. PubMed ID: 10679666
    [No Abstract]   [Full Text] [Related]  

  • 7. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
    Yang D; Holt GE; Velders MP; Kwon ED; Kast WM
    Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.
    Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y
    Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatography method for detecting prostate-specific membrane antigen activity.
    Kamga I; Ng R; Hosaka M; Berkman CE
    Anal Biochem; 2002 Nov; 310(1):125-7. PubMed ID: 12413483
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific membrane antigen.
    Maraj BH; Whelan P; Markham AF
    Br J Urol; 1998 Apr; 81(4):523-8. PubMed ID: 9598621
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy.
    Gong MC; Chang SS; Watt F; O'Keefe DS; Bacich DJ; Uchida A; Bander NH; Reuter VE; Gaudin PB; Molloy PL; Sadelian M; Heston WD
    Mol Urol; 2000; 4(3):217-22;discussion 223. PubMed ID: 11062377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues.
    Cunha AC; Weigle B; Kiessling A; Bachmann M; Rieber EP
    Cancer Lett; 2006 May; 236(2):229-38. PubMed ID: 16046056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
    Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
    J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
    Heston WD
    Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
    Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
    Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active specific immune therapy of prostate gland cancer].
    Chakŭrov S; Minchev M
    Khirurgiia (Sofiia); 2002; 58(1):32-8. PubMed ID: 12515033
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines.
    Grossmann ME; Wood M; Celis E
    World J Urol; 2001 Nov; 19(5):365-70. PubMed ID: 11760786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.
    Mincheff M; Tchakarov S; Zoubak S; Loukinov D; Botev C; Altankova I; Georgiev G; Petrov S; Meryman HT
    Eur Urol; 2000 Aug; 38(2):208-17. PubMed ID: 10895014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.